ArticleCancers2025

Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas.

Nicole Lisa Li-Ann Goh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.